Venetoclax Combined With Azacitidine for Consolidation Therapy in AML

Clinical trial NCT07425782 · RECRUITING

Trial details

NCT number: NCT07425782
Sponsor: The First Affiliated Hospital of Soochow University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Consolidation Therapy Venentoclax High Risk Hematopoietic Stem Cell Transplant (HSCT)

Start date: 2026-02-01
Primary completion: 2028-11-26
Enrollment: 216

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.